Trial NCT02485990

View at ClinicalTrials.gov 
Org. Study IDs: J15113
Secondary IDs: IRB00064379

Last trial update was posted on 2021-04-12

MeSH Interventions

Olaparib Tremelimumab

MeSH Conditions

Carcinoma

Other Conditions

Primary Peritoneal Carcinoma

Stopping Reasons

Withdrawal of sponsor support

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID